Lv3
280 积分 2024-08-27 加入
Identification of an m6A Natural Inhibitor, Lobeline, That Reverses Lenvatinib Resistance in Hepatocellular Tumors
3个月前
已完结
Functionalizing PLGA and PLGA Derivatives for Drug Delivery and Tissue Regeneration Applications
3个月前
已完结
Tyrosine Kinase Inhibitor Lenvatinib Based Nano Formulations and Cutting-Edge Scale-Up Technologies in revolutionizing Cancer Therapy
3个月前
已完结
A multifunctional nanotheranostic agent based on Lenvatinib for multimodal synergistic hepatocellular carcinoma therapy with remarkably enhanced efficacy
3个月前
已完结
Tumor-Targeted PLGA Nanospheres Enhance Therapeutic Effect of Lenvatinib in Hepatocellular Carcinoma via Photothermal and Photodynamic Therapy
3个月前
已完结
Fe3O4-viral-like Mesoporous Silica Nanoparticle(Fe3O4-vMSN)-Sustained Release of Lenvatinib for Targeted Treatment of Hepatocellular Carcinoma
3个月前
已完结
pH-Responsive Pluronic F127–Lenvatinib-Encapsulated Halogenated Boron-Dipyrromethene Nanoparticles for Combined Photodynamic Therapy and Chemotherapy of Liver Cancer
3个月前
已完结
Biotinylated polyaminoacid-based nanoparticles for the targeted delivery of lenvatinib towards hepatocarcinoma
3个月前
已完结
Multi-faceted nanodrug reinforcing metalloimmunotherapy for hepatocellular carcinoma
3个月前
已完结
A C-MET RECEPTOR TARGETING NANOPARTICLE PLATFORM FOR COMBINATION THERAPY AGAINST HEPATOCELLULAR CARCINOMA
3个月前
已关闭
皖公网安备34019202002308
